Fox Chase Cancer Center News

PHILADELPHIA (September 25, 2017) – In a trial of whether a modified method of radiation therapy for localized prostate cancer would more effectively preserve men’s sexual function, researchers at Fox Chase Cancer Center found no statistically significant benefit.

PHILADELPHIA (September 12, 2017) – Fox Chase Cancer Center is pleased to welcome Jerry Adams, PhD, director of Medicinal Chemistry, Immuno-Oncology, and Combinations at GlaxoSmithKline (GSK), as Visiting Professor. Adams will collaborate with several research teams, including those working on drug development and epigenetics.

PHILADELPHIA (September 11, 2017) – Dr. Kaiser is being recognized as one of the nation’s exemplary leaders of health systems who have demonstrated outstanding leadership and clinical expertise throughout their careers.

PHILADELPHIA (September 6, 2017) – The center of research excellence at the University of the West Indies will focus on cancer, diabetes, heart disease, and stroke. It is the planned first step toward developing a broader network of Caribbean centers of excellence, which will increase research collaboration to address these diseases throughout the region.

PHILADELPHIA (September 1, 2017) – Fox Chase Cancer Center is pleased to announce the hiring of Rashmi Khanal, who will join the Department of Hematology/Oncology at Fox Chase Cancer Center as part of the Jeanes Hospital Consultative Service.

PHILADELPHIA (September 1, 2017) - September is Prostate Cancer Awareness month, and Fox Chase Cancer Center is raising awareness on the signs and risk factors for prostate cancer.

PHILADELPHIA (August 21, 2017) – On September 10, Fox Chase Cancer Center and Temple Health will participate in the Race to Cure Sarcoma 2017 at Warminster Park, presented by the Sarcoma Foundation of America.

PHILADELPHIA (August 15, 2017) – "She is an outstanding clinician and has developed considerable expertise in the treatment of patients with hematologic malignancies and bone marrow transplantation,” said Martin J. Edelman, chair of the Department of Hematology/Oncology at Fox Chase.